US HER-2 Positive Breast Cancer Market Size, Share, Trend, Growth, Forecast 2015-2019

1
IT Services Market in Latin America
2015-2019Global Small Cell Lung Cancer
Therapeutics Market 2015-2019Global Small
Cell Lung Cancer Therapeutics Market
2015-2019HER-2 Positive Breast Cancer
Market in the US 2015-2019
Industry Size, Share, Global Trends, Demand,
Insights, Analysis, Research, Report, and
Forecast 2015- 2019
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
2
Report overview
Research Beam adds a report titled HER-2
Positive Breast Cancer Market in the US
2015-2019 that provides latest market trends and
opportunities. The report offers detailed
analysis of the US HER-2 Positive Breast Cancer
Industry. Breast cancer is characterized by
uncontrolled growth of cancerous cells in the
breast. It occurs in both males and females,
however, the incidence of breast cancer in males
is rare. Histologically, breast cancer can be
classified into ductal carcinoma, lobular
carcinoma, nipple cancer, and other
undifferentiated carcinoma. Breast cancer is the
second most common form of cancer in women. HER-2
is a protein that affects the growth of malignant
cells and is usually found on the surface of
normal breast cells. Sometimes, a large number of
HER-2 receptors are found on the surface of
breast cancer cells. These HER-2 receptors are
responsible for stimulating the growth and
division of malignant cancerous cells. This
condition is therefore known as HER-2 positive
breast cancer. HER-2 positive breast cancers have
a tendency to spread and metastasize more rapidly
than HER-2 negative breast cancers. HER-2
positive breast cancer is more prevalent in
females than males. In 2012, GLOBOCAN reported
that breast cancer accounted for 11.9 percent of
the total number of cancer cases and led to
522,000 deaths worldwide. HER-2 positive breast
cancer accounts for almost 25 percent of all
types of breast cancer. As per the Report, The
HER-2 Positive Breast Cancer market in US to grow
at a CAGR of 12.65 percent over the period
2014-2019.

3
Report overview
Covered in this Report This report covers the
present scenario and the growth prospects of the
HER-2 Positive Breast Cancer market in the US for
the period 2015-2019. To calculate the market
size, the report considers revenue generated
through the sales of targeted therapeutics and
chemotherapeutics used in the management of HER-2
positive breast cancer patients. The report
also presents the vendor landscape and a
corresponding detailed analysis of the top
vendors in the HER-2 Positive Breast Cancer
market in the US. In addition, it discusses the
major drivers that influence the growth of the
market. It also outlines the challenges faced by
the vendors and the market at large, as well as
the key trends that are emerging in the market.
HER-2 Positive Breast Cancer Market in US
2015-2019, has been prepared based on an in-depth
market analysis with inputs from industry
experts. The report covers the market landscape
of the HER-2 Positive Breast Cancer market in the
US and its growth prospects over the coming
years. The report also includes a discussion of
the key vendors operating in this market. Key
Vendors Celgene F. Hoffmann-La Roche
GlaxoSmithKline Novartis Sanofi

4
Report overview
Market Driver Increase in Population of Breast
Cancer Patients For a full, detailed list, view
our report Market Challenge Poor Diagnosis and
Screening For a full, detailed list, view our
report Market Trend Increase in Awareness
For a full, detailed list, view our report Key
Questions Answered in this Report What will the
market size be in 2019 and what will the growth
rate be? What are the key market trends? What
is driving this market? What are the challenges
to market growth? Who are the key vendors in
this market space? What are the market
opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? Enquire about report _at_
http//www.researchbeam.com/her-2-positive-breast-
cancer-in-the-us-2015-2019-market/enquire-about-re
port

5
Table of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Introduction 06. Disease
Overview 07. Market Landscape 08. Market
Segmentation by Type of Therapy 09. 9 Market
Segmentation by Molecule Type 10 Market
Segmentation by Route of Administration 11 Buying
Criteria 12 Market Growth Drivers 13 Drivers and
their Impact 14 Market Challenges 15 Impact of
Drivers and Challenges 16 Market Trends 17 Trends
and their Impact 18 Vendor Landscape 19 Key
Vendor Analysis 20 Other Reports in this Series

6
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/her-2-positive-breast-
cancer-in-the-us-2015-2019-market
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
Stay With Us